Evidence map›Paper›PMID 36894694›Full record

ReviewNature structural & molecular biology2023

cGAMP-activated cGAS-STING signaling: its bacterial origins and evolutionary adaptation by metazoans.

Dinshaw J Patel, You Yu, Wei Xie

Open access · bronzeAbstract readReview
In one paragraph

Review in Nature structural & molecular biology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 43 papers.

0numbers the graph read from it
0cells of the map it votes in
43citing papers in PubMed
9.4field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

43 citing papers in PubMed, 57 citations in OpenAlex.

  1. Review
  2. cGAS-STING as a Neuroimmune Traffic Molecule: Unraveling Pathogenic Mechanisms and Therapeutic Potential in Neurological Disorders.Journal of neuroimmune pharmacology : the official journal of the Society on NeuroImmune Pharmacology · 2026
    Review
  3. Article
  4. Article
  5. Extracellular cGAMP in health and disease.Molecular biomedicine · 2026
    Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. The cGAS-STING pathway in fibroblast microenvironment: from molecular mechanisms to targeted therapies.Apoptosis : an international journal on programmed cell death · 2026
    Review
  11. Article
  12. Review
  13. Review
  14. Article
  15. Article
  16. Review
  17. Article
  18. Review
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 2 institutions in 2 countries.

Dinshaw J PatelStructural Biology Program, Memorial Sloan-Kettering Cancer Center, New York, NY, USA. pateld@mskcc.org.ORCID 0000-0002-9779-7778
You YuStructural Biology Program, Memorial Sloan-Kettering Cancer Center, New York, NY, USA.
Wei XieCollege of Pharmaceutical Sciences, Zhejiang University, Hangzhou, Zhejiang, China.ORCID 0000-0002-4550-6211
Memorial Sloan Kettering Cancer Center · USZhejiang University · CN

Funding

X-RAY CRYSTALLOGRAPHYP30CA008748 · NCI · SLOAN-KETTERING INSTITUTE FOR CANCER RES · PI SELWYN M VICKERS · 1985 to 2026
$347.4M
Development of small molecule cGAS inhibitors for repression of dsDNA-triggered interferon expressionR01AI141507 · NIAID · ROCKEFELLER UNIVERSITY · PI TUSCHL, THOMAS · 2019 to 2022
$2.1M
'Class I and III Multi-subunit CRISPR-Cas Surveillance Complexes: Recognition, Cleavage, Autoimmunity and Inhibition’R01GM129430 · NIGMS · SLOAN-KETTERING INST CAN RESEARCH · PI PATEL, DINSHAW J · 2019 to 2022
$1.4M
Structure-Activity Based Mechanistic Insights into Cleavage Chemistry by Self-Cleaving Nucleolytic RibozymesR01GM145888 · NIGMS · SLOAN-KETTERING INST CAN RESEARCH · PI PATEL, DINSHAW J · 2022 to 2025
$1.3M
NCI NIH HHS P30 CA008748NIAID NIH HHS R01 AI141507NIGMS NIH HHS R01 GM129430NIGMS NIH HHS R01 GM145888
6 · The paper itself

Abstract

The metazoan cGAMP-activated cGAS-STING innate immunity pathway is triggered in response to genomic instability and DNA damage, thereby providing host defense against microbial pathogens. This pathway also impacts on autophagy, cellular senescence and antitumor immunity, while its overactivation triggers autoimmune and inflammatory diseases. Metazoan cGAS generates cGAMP containing distinct combinations of 3'-5' and 2'-5' linkages, which target the adaptor protein STING and activate the innate immune response through a signaling cascade leading to upregulation of cytokine and interferon production. This Review highlights a structure-based mechanistic perspective of recent advances in cGAMP-activated cGAS-STING innate immune signaling by focusing on the cGAS sensor, cGAMP second messenger and STING adaptor components, thereby elucidating the specificity, activation, regulation and signal transduction features of the pathway. In addition, the Review addresses progress towards identification of inhibitors and activators targeting cGAS and STING, as well as strategies developed by pathogens to evade cGAS-STING immunity. Most importantly, it highlights cyclic nucleotide second messengers as ancient signaling molecules that elicit a potent innate immune response that originated in bacteria and evolved through evolutionary adaptation to metazoans.

Indexed as

Immunity, InnateNucleotides, CyclicPhylogenySignal TransductionAnimalsNucleotidyltransferasesSTING Proteincyclic guanosine monophosphate-adenosine monophosphateNucleotides, CyclicNucleotidyltransferasesSTING1 protein, humanSTING Protein

Identifiers

PMID36894694
PMCPMC11749898
OpenAlexW4323670132

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.